Levetiracetam-Induced Parkinsonism: A Short Case Series

Levetiracetam-Induced Parkinsonism: A Short Case Series

Saved in:

Bibliographic Details
Main Authors:	Thomas Mathew, Amitoj S Chadha, Sita Jayalakshmi, Surabhi Garg, Aditya H Ravindranath, Uday Murgod, Shagun Bhardwaj, Pranjali Ektare, Saji K John, Raghunandan Nadig, Gosala RK Sarma
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Series:	Annals of Indian Academy of Neurology
Online Access:	https://journals.lww.com/10.4103/aian.aian_430_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association of interictal epileptiform discharges and serum concentration of levetiracetam and lamotrigine
by: Johannes D. Lang, et al.
Published: (2025-01-01)

Hallucination in a Seizure Patient Using Levetiracetam: A Case Report
by: D. R. Shakya, et al.
Published: (2012-01-01)

Levetiracetam versus Phenobarbitone in Neonatal Seizures - An Open label Randomized Controlled Trial
by: Nikhil D Kulkarni, et al.
Published: (2025-01-01)

A meta-analytic evaluation of the efficacy and safety of levetiracetam for treating myoclonic seizures
by: Sara Najafi, et al.
Published: (2025-02-01)

Levetiracetam-induced drug reaction: violaceous discrete maculopapular rash: A case report
by: Arvinpreet Kour, et al.
Published: (2023-01-01)

Evaluating the Efficacy of Levetiracetam on Non-Cognitive Symptoms and Pathology in a Tau Mouse Model
by: Jackson C. Thompson, et al.
Published: (2024-12-01)

Levetiracetam Induced Behavioral Abnormalities in a Patient with Seizure Disorder: A Diagnostic Challenge
by: Oluwaseun Ogunsakin, et al.
Published: (2020-01-01)

Chromatographic Characterization and Method Development for Determination of Levetiracetam in Saliva: Application to Correlation with Plasma Levels
by: Imad I. Hamdan, et al.
Published: (2017-01-01)

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
by: Cerine C. Hansen, et al.
Published: (2018-01-01)

Phytomedicine nanoformulations for Parkinson's disease
by: Chinthu V. Saji, et al.
Published: (2025-02-01)

Enantioselective Synthesis of Antiepileptic Drug: (-)-Levetiracetam—Synthetic Applications of the Versatile New Chiral N-Sulfinimine
by: K. Chandra Babu, et al.
Published: (2013-01-01)

Bilateral Reversible Corneal Edema as a Novel Side-Effect of Levetiracetam – A Case Report
by: Caruana K, et al.
Published: (2024-12-01)

Levetiracetam Ameliorates L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats Inducing Critical Molecular Changes in the Striatum
by: Huan Du, et al.
Published: (2015-01-01)

Determination of Levetiracetam in Human Plasma by Dispersive Liquid-Liquid Microextraction Followed by Gas Chromatography-Mass Spectrometry
by: Greyce Kelly Steinhorst Alcantara, et al.
Published: (2016-01-01)

Piriformis Syndrome as a Cause of Non-discogenic Sciatic Pain in a Young Bharatanatyam Dancer
by: Thomas Mathew, et al.
Published: (2024-12-01)

Excellent response to levetiracetam for recurrent prolonged sleep attacks in an 18-year-old male: a case report
by: Faisal Alfaksh, et al.
Published: (2024-12-01)

Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience
by: Raffaele Falsaperla, et al.
Published: (2019-01-01)

Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials
by: Tao Xiong, et al.
Published: (2019-07-01)

Effects of Levetiracetam and Lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy
by: Andrea Bianconi, et al.
Published: (2024-01-01)

Controlled Evaluation of Serum Lipid Levels and Carotid Artery Intima Media Thickness in Epileptic Children Treated with Valproic Acid, Carbamazepine and Levetiracetam
by: Betül AKSOY, et al.
Published: (2024-12-01)

Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
by: Kristen D. Onos, et al.
Published: (2022-01-01)

Letter to the editor “Effects of levetiracetam and lacosamide on survival and seizure control in IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy”
by: Niher Tabassum Snigdha
Published: (2024-01-01)

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial
by: Arjune Sen, et al.
Published: (2024-12-01)

Lump in the Muscle: Should We Forget a Rare Cause?
by: Amitoj Sidhu, et al.
Published: (2025-01-01)

Determinants of Caregiver Burden in Stroke Survivors who Underwent Decompressive Craniectomy
by: Karnam Anand, et al.
Published: (2024-12-01)

Complex of Hybrid Diabetes Mellitus With Severe Insulin Resistance and Cerebrovascular Complications: A Case Report
by: Pranjali Shah
Published: (2024-10-01)

Prolonged Honeymoon Phase in Adult-Onset Type 1 Diabetes Mellitus: A Case Study
by: Pranjali Shah
Published: (2024-04-01)

Letter to the editor concerning “effects of Levetiracetam and Lacosamide on survival and seizure control in 2IDH-wild type glioblastoma during temozolomide plus radiation adjuvant therapy” by Andrea Bianconi et al
by: Karthikeyan Kandaswamy, et al.
Published: (2024-01-01)

Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II)
by: Girvan Burnside, et al.
Published: (2020-08-01)

Efficient Feature Selection and Hyperparameter Tuning for Improved Speech Signal-Based Parkinson’s Disease Diagnosis via Machine Learning Techniques
by: Deepak Painuli, et al.
Published: (2025-01-01)

Fermionic entanglement in the presence of background electric and magnetic fields
by: Shagun Kaushal
Published: (2025-01-01)

Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms
by: Maria João da Costa Caiado, et al.
Published: (2025-02-01)

Risk factors for falls in Parkinson's disease and other parkinsonisms
by: Aleksandra Buczek, et al.
Published: (2024-12-01)

Orthostatic Hypotension in Patients with Parkinson’s Disease and Atypical Parkinsonism
by: Seyed-Mohammad Fereshtehnejad, et al.
Published: (2014-01-01)

Electrolyte and electrolyte-additives for improved plasma electrolytic oxidation on magnesium alloys
by: Viswanathan S. Saji
Published: (2025-03-01)

Parkinson's Disease
by: Flavio Fröhlich
Published: (2018-08-01)

Prodromal Parkinson’s disease and subsequent risk of Parkinson’s disease and mortality
by: Xiao Chen, et al.
Published: (2025-01-01)

Dance for Parkinson, multifaceted experiences of persons living with Parkinson’s Disease
by: Ingrid Andreasson, et al.
Published: (2024-12-01)

Keluwih (Artocarpus camansi) extract effects in zebrafish models of Parkinson’s disease
by: Marisca Evalina Gondokesumo, et al.
Published: (2023-05-01)

Treatment of periodontal infrabony defect using particulate dentin graft and recombinant human platelet-derived growth factor
by: Vishal Garg, et al.
Published: (2024-07-01)